(Q34112075)

31 July 2017

title

Cognitive effects of risperidone in children with autism and irritable behavior (English)

1 reference

31 July 2017

0 references

1 reference

1 reference

4

1 reference

31 July 2017

Christopher J McDougle

series ordinal

3

object named as

Christopher J McDougle

1 reference

31 July 2017

7

L Eugene Arnold

1 reference

31 July 2017

12

Naomi Swiezy

1 reference

31 July 2017

8

Benedetto Vitiello

1 reference

31 July 2017

1

Michael G Aman

1 reference

31 July 2017

5

Elaine Tierney

1 reference

31 July 2017

11

Pegeen Cronin

1 reference

31 July 2017

2

Jill A Hollway

1 reference

31 July 2017

14

Kathleen Koenig

1 reference

31 July 2017

15

Jaswinder K Ghuman

1 reference

31 July 2017

10

Allison Gavaletz

1 reference

31 July 2017

13

Courtney Wheeler

1 reference

31 July 2017

16

David J Posey

1 reference

31 July 2017

James T McCracken

6

1 reference

31 July 2017

Louise Ritz

series ordinal

9

1 reference

31 July 2017

publication date

1 June 2008

1 reference

Journal of Child and Adolescent Psychopharmacology

31 July 2017

published in

1 reference

31 July 2017

volume

18

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

227-236

1 reference

Acute and long-term safety and tolerability of risperidone in children with autism

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

On the trail of a cognitive enhancer for the treatment of schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

Rate-decreasing effects of the atypical neuroleptic risperidone attenuated by conditions of reinforcement in a woman with mental retardation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

Risperidone in children with autism and serious behavioral problems

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network. Research Units on Pediatric Psychopharmacology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

Cognitive improvement in schizophrenia with novel antipsychotic medications

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

Performance of patients with schizophrenia on a pen and paper visuospatial working memory task with short delay

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

Methylphenidate and thioridazine in the treatment of intellectually subaverage children: effects on cognitive-motor performance.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

The Purdue pegboard; norms and studies of reliability and validity.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

Risperidone and cognitive function in children with disruptive behavior disorders

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

Adverse effects of risperidone on spatial working memory in first-episode schizophrenia

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

Neuropsychological effects of risperidone in children with pervasive developmental disorders: a blinded discontinuation study.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

The effects of clozapine and risperidone on spatial working memory in schizophrenia

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

The influence of risperidone on attentional functions in children and adolescents with attention-deficit/hyperactivity disorder and co-morbid disruptive behavior disorder

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18582177

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1089/CAP.2007.0133

1 reference

31 July 2017

1 reference

31 July 2017

1 reference